EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease

Rens de Groot, Patricia Badía Folgado, Kazuhiro Yamamoto, Daniel R Martin, Christopher D Koch, Danielle Debruin, Sophie Blagg, Alexander F Minns, Sumit Bhutada, Josefin Ahnström, Jonathan Larkin, Anders Aspberg und 3 weitere

Matrix Biology · 2025

DOI: 10.1016/j.matbio.2024.12.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Matrix Biology, 2025. Verfasst von Rens de Groot und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Science, University College London, 51 Chenies Mews, London WC1E 6HX, United Kingdom. Electronic address: r.degroot@ucl.a…. Hauptthemen laut MEDLINE: Cartilage Oligomeric Matrix Protein, ADAMTS4 Protein, Osteoarthritis, Epitopes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIAMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a highly prevalent joint disease, affecting millions of people worldwide and characterized by degradation of articular cartilage, subchondral bone remodeling and low-grade inflammation, leading to pain, stiffness and disability. Cartilage Oligomeric Matrix Protein (COMP) is a major structural component of cartilage and its degradation has been proposed as a marker of OA severity/progression. Several proteases cleave COMP in vitro, however, it is unclear which of these COMPase activities is prevalent in an osteoarthritic joint. Here, using purified recombinant proteins, we show that A Disintegrin And Metalloproteinase with Thrombospondin motifs 4 (ADAMTS4) is the most potent COMPase, followed by ADAMTS1. Using liquid chromatography-tandem mass spectrometry, we identified several novel cleavage sites in COMP resulting from ADAMTS4 and ADAMTS1 activity. Cleavage at S77-V78 disrupted the pentameric organization of COMP and generated a neopeptide previously identified in the synovial fluid of OA patients. Immunoblots with anti-QQS77 antibodies confirmed that ADAMTS4 efficiently cleaved this peptide bond. By analyzing five ADAMTS4 variants, we found that the C-terminal spacer domain is strictly necessary for COMPase activity and identified the specific residues involved in the interaction with COMP. An inhibitory anti-ADAMTS4 antibody significantly decreased generation of the COMP QQS77 neoepitope in human OA cartilage explants, implicating ADAMTS4 as a key protease in generating the QQS77 neopeptides in OA. Since another major ADAMTS4 substrate is aggrecan, the most abundant proteoglycan in cartilage, these findings highlight that, by cleaving both COMP and aggrecan, ADAMTS4 may play a crucial role in modulating the structural integrity of cartilage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cartilage Oligomeric Matrix ProteinADAMTS4 ProteinOsteoarthritisEpitopesHumansProteolysisCartilage, ArticularProcollagen N-EndopeptidaseADAMTS1 Protein

Stichwörter der Autor:innen

ADAMTSADAMTS4BiomarkerCartilage oligomeric matrix proteinExtracellular matrixNeoepitopeOsteoarthritisProteolysis

Substanzen

Cartilage Oligomeric Matrix ProteinADAMTS4 ProteinEpitopesProcollagen N-EndopeptidaseADAMTS1 ProteinADAMTS4 protein, humanADAMTS1 protein, humanTSP5 protein, human

Autor:innen und Institutionen

  • Institute of Cardiovascular Science, University College London, 51 Chenies Mews, London WC1E 6HX, United Kingdom. Electronic address: r.degroot@ucl.ac.uk.
  • Department of Immunology and Inflammation, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom.
  • Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, 6 West Derby Street, Liverpool L7 8TX, United Kingdom.
  • Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
  • Department of Biochemical Sciences, School of Biosciences, Faculty of Health and Medical Sciences, Edward Jenner Building, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom.
  • SynOA Therapeutics, Philadelphia, PA, USA; Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.

Förderung

  • Wellcome Trust
  • NIAMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • British Heart Foundation
  • Foundation for the National Institutes of Health
  • Versus Arthritis
  • Arthritis Foundation

Zitieren

APA

de Groot, R., Folgado, P. B., Yamamoto, K., Martin, D. R., Koch, C. D., Debruin, D., Blagg, S., Minns, A. F., Bhutada, S., Ahnström, J., Larkin, J., Aspberg, A., Önnerfjord, P., Apte, S. S., & Santamaria, S. (2025). Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease. Matrix Biology. https://doi.org/10.1016/j.matbio.2024.12.005

Vancouver

de Groot R, Folgado PB, Yamamoto K, Martin DR, Koch CD, Debruin D, et al. Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease. Matrix Biology. 2025. doi:10.1016/j.matbio.2024.12.005

BibTeX
@article{deGroot2025,
  author = {de Groot, Rens and Folgado, Patricia Badía and Yamamoto, Kazuhiro and Martin, Daniel R and Koch, Christopher D and Debruin, Danielle and Blagg, Sophie and Minns, Alexander F and Bhutada, Sumit and Ahnström, Josefin and Larkin, Jonathan and Aspberg, Anders and Önnerfjord, Patrik and Apte, Suneel S and Santamaria, Salvatore},
  title = {Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease},
  journal = {Matrix Biology},
  year = {2025},
  doi = {10.1016/j.matbio.2024.12.005}
}
Kostenlos starten →